# PAROXETINE HYDROCHLORIDE
> **ANDA212645** · Abbreviated New Drug Application (Generic) · Sponsor: CADILA PHARMS LTD · Approved 2021-08-27
## Drug
- **FDA Application Number:** ANDA212645
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PAROXETINE HYDROCHLORIDE
- **Generic name:** PAROXETINE
- **Active ingredients:** PAROXETINE HYDROCHLORIDE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** CADILA PHARMS LTD
- **Manufacturer:** Modavar Pharmaceuticals LLC
- **First approval:** 2021-08-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212645)
---
*MORVS · CC0 1.0*